These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28215231)

  • 1. Use of varenicline in smokeless tobacco cessation influences sleep quality and dream recall frequency but not dream affect.
    Polini F; Principe R; Scarpelli S; Clementi F; De Gennaro L
    Sleep Med; 2017 Feb; 30():1-6. PubMed ID: 28215231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.
    Baker TB; Piper ME; Stein JH; Smith SS; Bolt DM; Fraser DL; Fiore MC
    JAMA; 2016 Jan; 315(4):371-9. PubMed ID: 26813210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep-related adverse events of smoking cessation drugs: A network meta-analysis of randomized controlled trials.
    Song Y; Park YA; Lee DH; Yee J; Gwak HS
    Psychiatry Res; 2024 May; 335():115874. PubMed ID: 38564922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-sleep treatment with galantamine stimulates lucid dreaming: A double-blind, placebo-controlled, crossover study.
    LaBerge S; LaMarca K; Baird B
    PLoS One; 2018; 13(8):e0201246. PubMed ID: 30089135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varenicline and abnormal sleep related events.
    Savage RL; Zekarias A; Caduff-Janosa P
    Sleep; 2015 May; 38(5):833-7. PubMed ID: 25409105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world effectiveness of varenicline versus nicotine replacement therapy in patients with and without psychiatric disorders.
    Kaduri P; Voci S; Zawertailo L; Chaiton M; McKenzie K; Selby P
    J Addict Med; 2015; 9(3):169-76. PubMed ID: 25622124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical Validation of Self-Reported Smokeless Tobacco Abstinence among Smokeless Tobacco Users: Results from a Clinical Trial of Varenicline in India.
    Jain R; Jhanjee S; Jain V; Gupta T; Mittal S; Chauhan P; Raghav R; Goelz P; Schnoll RA
    J Psychoactive Drugs; 2015; 47(4):331-5. PubMed ID: 26317285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the Effects of Varenicline on Craving, Withdrawal, and Affect in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline for Smokeless Tobacco Dependence in India.
    Jhanjee S; Jain R; Jain V; Gupta T; Mittal S; Goelz P; Schnoll RA
    J Psychoactive Drugs; 2015; 47(4):325-30. PubMed ID: 26317176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.
    Rohsenow DJ; Tidey JW; Martin RA; Colby SM; Swift RM; Leggio L; Monti PM
    Addiction; 2017 Oct; 112(10):1808-1820. PubMed ID: 28498504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic system and dream recall: An MRI study in Parkinson's disease patients.
    De Gennaro L; Lanteri O; Piras F; Scarpelli S; Assogna F; Ferrara M; Caltagirone C; Spalletta G
    Hum Brain Mapp; 2016 Mar; 37(3):1136-47. PubMed ID: 26704150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dream recall and its relationship to sleep, perceived stress, and creativity among adolescents.
    Brand S; Beck J; Kalak N; Gerber M; Kirov R; Pühse U; Hatzinger M; Holsboer-Trachsler E
    J Adolesc Health; 2011 Nov; 49(5):525-31. PubMed ID: 22018568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco quitline outcomes by service type.
    Kerkvliet JL; Fahrenwald NL
    S D Med; 2014 Jan; 67(1):25-9. PubMed ID: 24601063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of transdermal nicotine patches on sleep and dreams.
    Page F; Coleman G; Conduit R
    Physiol Behav; 2006 Jul; 88(4-5):425-32. PubMed ID: 16782142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G
    Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of clinical smoking cessation interventions in Thailand.
    Tosanguan J; Chaiyakunapruk N
    Addiction; 2016 Feb; 111(2):340-50. PubMed ID: 26360507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the end of COVID confinement on pandemic dreams, as assessed by a weekly sleep diary: a longitudinal investigation in Italy.
    Scarpelli S; Gorgoni M; Alfonsi V; Annarumma L; Di Natale V; Pezza E; De Gennaro L
    J Sleep Res; 2022 Feb; 31(1):e13429. PubMed ID: 34288197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.
    Tonstad S; Davies S; Flammer M; Russ C; Hughes J
    Drug Saf; 2010 Apr; 33(4):289-301. PubMed ID: 20297861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S; Patel PN
    Cardiol Rev; 2007; 15(3):154-61. PubMed ID: 17438382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.